Reginald Love Sells 5,091 Shares of Strata Critical Medical (NASDAQ:SRTA) Stock

Strata Critical Medical (NASDAQ:SRTA) Director Reginald Love sold 5,091 shares of the stock in a transaction on Monday, August 10th. The stock was sold at an average price of $5.75, for a total transaction of $29,273.25. Following the sale, the director directly owned 146,481 shares in the company, valued at $842,265.75. This trade represents a 3.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Strata Critical Medical Stock Performance

Strata Critical Medical stock opened at $5.90 on Friday. Strata Critical Medical has a 1 year low of $3.85 and a 1 year high of $6.50. The business has a 50-day simple moving average of $5.44. The company has a market cap of $510.53 million, a P/E ratio of -147.50 and a beta of 2.25.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the stock. Allied Private Wealth LLC acquired a new stake in Strata Critical Medical in the second quarter worth $31,000. Granite Investment Partners LLC boosted its holdings in shares of Strata Critical Medical by 77.0% during the first quarter. Granite Investment Partners LLC now owns 18,181 shares of the company’s stock valued at $76,000 after acquiring an additional 7,911 shares during the period. Seelaus Asset Management LLC boosted its holdings in shares of Strata Critical Medical by 32.7% during the first quarter. Seelaus Asset Management LLC now owns 24,350 shares of the company’s stock valued at $102,000 after acquiring an additional 6,000 shares during the period. Principal Financial Group Inc. bought a new position in shares of Strata Critical Medical during the first quarter worth about $537,000. Finally, Quantinno Capital Management LP grew its position in shares of Strata Critical Medical by 98.7% during the first quarter. Quantinno Capital Management LP now owns 143,239 shares of the company’s stock worth $599,000 after acquiring an additional 71,155 shares during the last quarter. 47.36% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Separately, Weiss Ratings cut shares of Strata Critical Medical from a “hold (c)” rating to a “hold (c-)” rating in a report on Wednesday, August 5th. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, Strata Critical Medical presently has a consensus rating of “Moderate Buy” and a consensus target price of $8.00.

About Strata Critical Medical

Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.